Back to results
US 10,091,983 B2Granted
Cryopreservation of viable human skin substitutes
AssigneeStratatech Corporation
InventorsB. Lynn Allen-Hoffmann, John C. Pirnstill, Kenneth R. Gratz, Allen R. Comer
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to systems and methods for preparing, storing, shipping and using skin equivalents made by organotypic culture. In particular, the present invention relates to systems and methods for cryopreserving viable skin substitutes.
Claims9
A method of cryopreserving an organotypically cultured skin equivalent to maintain viable tissue comprising:
- treating an organotypically cultured skin equivalent in a cryoprotectant solution in a single step, wherein said organotypically cultured skin equivalent comprises stratified squamous epithelia on a dermal layer comprising fibroblasts embedded in collagen, and wherein the cryoprotectant solution comprises glycerol in an amount that is about 21% to about 70% of the cryoprotectant solution by volume;
- separating the treated organotypically cultured skin equivalent from excess cryoprotectant solution to provide a treated skin equivalent that is substantially free of excess cryoprotectant on the exterior surfaces of the skin equivalent;
- packaging said organotypically cultured skin equivalent in the absence of additional cryoprotectant to provide a packaged skin equivalent;
- and
- freezing said packaged organotypically cultured skin equivalent to provide a cryopreserved skin equivalent that retains viability after thawing.
2 more elements
A method of producing a cryopreserved skin equivalent comprising:
- providing a culture dish comprising an insert movable between upper and lower positions in said culture dish, said insert having a bottom planar surface formed from a porous membrane,
- forming a dermal equivalent comprising fibroblast cells on said porous membrane in said insert, wherein said insert is placed in said upper position in said culture dish,
- culturing said fibroblast cells to form a dermal equivalent,
- applying keratinocytes to said dermal equivalent,
- culturing said keratinocytes in a culture medium under conditions such that said keratinocytes form a skin equivalent comprising stratified epithelium,
- removing said culture medium,
- lowering said insert to said lower position,
- treating said skin equivalent with a cryoprotectant solution wherein the cryoprotectant solution comprises glycerol in an amount that is about 21% to about 70% of the cryoprotectant solution by volume,
- separating the treated organotypically cultured skin equivalent from excess cryoprotectant solution to provide a treated skin equivalent that is substantially free of excess cryoprotectant on the exterior surfaces of the skin equivalent, and
- freezing said skin equivalent in said culture dish in the absence of additional cryoprotectant to provide a cryopreserved skin equivalent that retains viability after thawing.
7 more elements
Dependencies are inferred from the claim text.